arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Zura Bio Limited

ZURA Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$3.39
▼ -17.9% Today
as of Oct 23, 14:22 ET
Last 30 days -34.93% Sep 14 → Oct 23
$3.24 $3.77 $4.30 $4.83 $5.36 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$4.38
High
$4.47
Low
$3.50
Volume
$9M
Avg Vol
$1M
Mkt Cap
$397M
P/E (TTM)
—
Beta
—
52w High
$7.44
52w Low
$3.25
Div Yield
—
Shares Out
$95M

Recent Press Releases & News last 60 days · 2 items

Sep 11 · 05:35 Insider Monkey
Zura Bio (ZURA) Hits Enrollment Milestones As Losses Widen Sharply
Aug 31 · 20:30 PR Business Wire
Zura Bio to Participate in the Cantor Global Healthcare Conference

ZURA earnings at a glance

The options market is pricing a move of about ±56.9% after the report, a range of roughly $1.46 to $5.32 from today's $3.39. Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±4.8% on average; after the most recent report on May 7, 2026 it moved -7.2%. That means options currently expect more movement than ZURA has typically delivered. ZURA beat the consensus EPS estimate in 1 of its last 4 reported quarters. Implied volatility is currently 482%. The share price of $3.39 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$3.25
$7.44
3% of range
Avg surprise (last 4)
-10.3%
Avg reaction (last 2)
-2.4%
50% positive
Latest IV / EM
482%
EM ±56.9% · $5 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-2.76$-2.07$-1.39$-0.71$-0.02 Actual $-2.76Actual $-1.31Actual $-0.18Actual $-0.02Actual $-0.17Actual $-0.26Actual $-0.19Est $-0.17Actual $-0.17Est $-0.19Actual $-0.21Est $-0.19Actual $-0.22Est $-0.17Actual $-0.21 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-26M$-24M$-22M$-19M$-17M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.21 — — — — financials
Thu May 7, 2026Mar/2026 $-0.22 $-0.17 -29.4% -15.8% -7.2% earnings
Thu Nov 13, 2025Sep/2025 $-0.21 $-0.19 -10.5% — — earnings
Thu Aug 14, 2025Jun/2025 $-0.17 $-0.19 +10.5% — — earnings
Thu May 8, 2025Mar/2025 $-0.19 $-0.17 -11.8% — +2.4% earnings
Mon Sep 30, 2024Sep 2024 $-0.26 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.17 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.02 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.18 — — — — financials
Fri Jun 30, 2023Jun 2023 $-1.31 — — — — financials
Fri Mar 31, 2023Mar 2023 $-2.76 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue————————
Cost of revenue————————
Gross profit————————
Operating income$-29M$-25M—$-20M$-18M$-19M—$-19M
Net income$-26M$-24M—$-18M$-16M$-17M—$-21M
EPS (diluted)$-0.21$-0.22—$-0.21$-0.17$-0.19—$-0.26

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$205M$226M$109M$139M$154M$171M$176M$188M
Inventory————————
Total current assets$210M$227M$112M$142M$157M$172M$179M$189M
Total assets$213M$229M$114M$144M$158M$172M$180M$189M
Long-term debt————————
Total liabilities$16M$12M$12M$25M$19M$21M$20M$18M
Total equity$197M$217M$102M$108M$127M$140M$147M$154M

Implied volatility — last 90 days

16%440%864%1288%1712% Jun 07 — IV 499% · EM ±69.1%Jun 10 — IV 429% · EM ±50.7%Jun 11 — IV 453% · EM ±50.0%Jun 15 — IV 808% · EM ±58.4%Jun 16 — IV 1712% · EM ±101.1%Jun 22 — IV 17% · EM ±3.5%Jun 23 — IV 23% · EM ±4.6%Jun 25 — IV 90% · EM ±17.6%Jun 26 — IV 98% · EM ±18.7%Jun 29 — IV 73% · EM ±12.9%Jul 01 — IV 86% · EM ±14.4%Jul 02 — IV 48% · EM ±7.7%Jul 03 — IV 50% · EM ±7.7%Jul 07 — IV 63% · EM ±8.4%Jul 08 — IV 103% · EM ±12.9%Jul 09 — IV 131% · EM ±15.4%Jul 15 — IV 173% · EM ±10.2%Jul 16 — IV 244% · EM ±10.2%Jul 20 — IV 205% · EM ±48.5%Jul 21 — IV 81% · EM ±18.8%Jul 22 — IV 202% · EM ±46.3%Jul 23 — IV 143% · EM ±32.1%Jul 24 — IV 106% · EM ±23.4%Jul 27 — IV 69% · EM ±14.4%Jul 28 — IV 95% · EM ±19.4%Jul 29 — IV 116% · EM ±23.2%Jul 30 — IV 244% · EM ±47.8%Jul 31 — IV 255% · EM ±48.8%Aug 03 — IV 271% · EM ±48.0%Aug 04 — IV 84% · EM ±14.5%Aug 05 — IV 281% · EM ±47.0%Aug 06 — IV 284% · EM ±46.0%Aug 07 — IV 279% · EM ±43.6%Aug 10 — IV 128% · EM ±17.8%Aug 11 — IV 351% · EM ±46.3%Aug 12 — IV 173% · EM ±21.6%Aug 13 — IV 180% · EM ±21.3%Aug 14 — IV 110% · EM ±12.1%Aug 17 — IV 153% · EM ±12.8%Aug 18 — IV 315% · EM ±22.8%Aug 19 — IV 493% · EM ±29.1%Aug 20 — IV 604% · EM ±25.2%Aug 24 — IV 59% · EM ±12.3%Aug 25 — IV 112% · EM ±22.9%Aug 26 — IV 182% · EM ±36.4%Aug 27 — IV 202% · EM ±39.6%Aug 28 — IV 189% · EM ±36.2%Aug 31 — IV 102% · EM ±18.1%Sep 01 — IV 97% · EM ±16.6%Sep 02 — IV 132% · EM ±22.0%Sep 03 — IV 221% · EM ±35.8%Sep 04 — IV 512% · EM ±80.0%Sep 07 — IV 255% · EM ±35.3%Sep 08 — IV 272% · EM ±35.9%Sep 09 — IV 150% · EM ±18.8%Sep 10 — IV 165% · EM ±19.5%Sep 11 — IV 112% · EM ±12.4%Sep 14 — IV 109% · EM ±9.1%Sep 15 — IV 161% · EM ±11.7%Sep 16 — IV 367% · EM ±21.7%Sep 17 — IV 463% · EM ±19.4%Sep 21 — IV 111% · EM ±23.3%Sep 22 — IV 96% · EM ±19.6%Sep 23 — IV 122% · EM ±24.4%Sep 24 — IV 132% · EM ±25.8%Sep 25 — IV 149% · EM ±28.5%Sep 28 — IV 135% · EM ±24.0%Sep 29 — IV 174% · EM ±30.0%Sep 30 — IV 295% · EM ±49.3%Oct 01 — IV 187% · EM ±30.2%Oct 02 — IV 304% · EM ±47.4%Oct 06 — IV 461% · EM ±60.9%Oct 07 — IV 373% · EM ±46.8%Oct 08 — IV 482% · EM ±56.9%

Sector peers

KYTX
Kyverna Therapeutics, Inc.
$403M $5.37-8.1%
EDIT
Editas Medicine, Inc.
$387M $2.36-6.0%
AGEN
Agenus Inc.
$376M $6.32-1.3%
FENC
Fennec Pharmaceuticals Inc.
$365M $10.02-3.5%
TECX
Tectonic Therapeutic, Inc.
$444M $20.06-8.2%
CCCC
C4 Therapeutics, Inc.
$347M $3.05-3.8%

ZURA earnings FAQ

What is ZURA's expected move for earnings?

Options currently price a move of about ±56.9%, or $1.93 per share either way from $3.39.

How does ZURA stock usually react to earnings?

Across the last 2 reports the average next-day move was ±4.8%, up 1 times and down 1 times.

What is ZURA's implied volatility?

ZURA's at-the-money implied volatility is about 482% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in